325 related articles for article (PubMed ID: 27784785)
21. Comprehensive Detection of Isopeptides between Human Tissue Transglutaminase and Gluten Peptides.
Lexhaller B; Ludwig C; Scherf KA
Nutrients; 2019 Sep; 11(10):. PubMed ID: 31547042
[TBL] [Abstract][Full Text] [Related]
22. Gliadin T cell epitope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the transamidation versus deamidation process.
Fleckenstein B; Molberg Ø; Qiao SW; Schmid DG; von der Mülbe F; Elgstøen K; Jung G; Sollid LM
J Biol Chem; 2002 Sep; 277(37):34109-16. PubMed ID: 12093810
[TBL] [Abstract][Full Text] [Related]
23. TG2-gluten complexes as antigens for gluten-specific and transglutaminase-2 specific B cells in celiac disease.
Lindstad CB; Dewan AE; Stamnaes J; Sollid LM; du Pré MF
PLoS One; 2021; 16(11):e0259082. PubMed ID: 34731200
[TBL] [Abstract][Full Text] [Related]
24. T-cell and B-cell immunity in celiac disease.
du Pré MF; Sollid LM
Best Pract Res Clin Gastroenterol; 2015 Jun; 29(3):413-23. PubMed ID: 26060106
[TBL] [Abstract][Full Text] [Related]
25. Transglutaminase 2-targeted autoantibodies in celiac disease: Pathogenetic players in addition to diagnostic tools?
Lindfors K; Mäki M; Kaukinen K
Autoimmun Rev; 2010 Sep; 9(11):744-9. PubMed ID: 20547248
[TBL] [Abstract][Full Text] [Related]
26. Transglutaminase 2 affinity and enzyme-substrate intermediate stability as determining factors for T-cell responses to gluten peptides in celiac disease.
Amundsen SF; Stamnaes J; du Pré MF; Sollid LM
Eur J Immunol; 2022 Sep; 52(9):1474-1481. PubMed ID: 35715890
[TBL] [Abstract][Full Text] [Related]
27. Interplay between Type 2 Transglutaminase (TG2), Gliadin Peptide 31-43 and Anti-TG2 Antibodies in Celiac Disease.
Martucciello S; Sposito S; Esposito C; Paolella G; Caputo I
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32456177
[TBL] [Abstract][Full Text] [Related]
28. Immunogenic peptides can be detected in whole gluten by transamidating highly susceptible glutamine residues: implication in the search for gluten-free cereals.
Mamone G; Camarca A; Fierro O; Sidney J; Mazzarella G; Addeo F; Auricchio S; Troncone R; Sette A; Gianfrani C
J Agric Food Chem; 2013 Jan; 61(3):747-54. PubMed ID: 23244345
[TBL] [Abstract][Full Text] [Related]
29. Transglutaminase 2-specific coeliac disease autoantibodies induce morphological changes and signs of inflammation in the small-bowel mucosa of mice.
Kalliokoski S; Piqueras VO; Frías R; Sulic AM; Määttä JA; Kähkönen N; Viiri K; Huhtala H; Pasternack A; Laurila K; Sblattero D; Korponay-Szabó IR; Mäki M; Caja S; Kaukinen K; Lindfors K
Amino Acids; 2017 Mar; 49(3):529-540. PubMed ID: 27503559
[TBL] [Abstract][Full Text] [Related]
30. Local communication among mucosal immune cells in patients with celiac disease.
van Bergen J; Mulder CJ; Mearin ML; Koning F
Gastroenterology; 2015 May; 148(6):1187-94. PubMed ID: 25623043
[TBL] [Abstract][Full Text] [Related]
31. Unexpected role of surface transglutaminase type II in celiac disease.
Maiuri L; Ciacci C; Ricciardelli I; Vacca L; Raia V; Rispo A; Griffin M; Issekutz T; Quaratino S; Londei M
Gastroenterology; 2005 Nov; 129(5):1400-13. PubMed ID: 16285941
[TBL] [Abstract][Full Text] [Related]
32. Celiac anti-type 2 transglutaminase antibodies induce phosphoproteome modification in intestinal epithelial Caco-2 cells.
Paolella G; Caputo I; Marabotti A; Lepretti M; Salzano AM; Scaloni A; Vitale M; Zambrano N; Sblattero D; Esposito C
PLoS One; 2013; 8(12):e84403. PubMed ID: 24391952
[TBL] [Abstract][Full Text] [Related]
33. Intestinal TG3- and TG2-Specific Plasma Cell Responses in Dermatitis Herpetiformis Patients Undergoing a Gluten Challenge.
Sankari H; Hietikko M; Kurppa K; Kaukinen K; Mansikka E; Huhtala H; Laurila K; Reunala T; Hervonen K; Salmi T; Lindfors K
Nutrients; 2020 Feb; 12(2):. PubMed ID: 32069794
[TBL] [Abstract][Full Text] [Related]
34. Type 2 Transglutaminase in Coeliac Disease: A Key Player in Pathogenesis, Diagnosis and Therapy.
Paolella G; Sposito S; Romanelli AM; Caputo I
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886862
[TBL] [Abstract][Full Text] [Related]
35. Autoantibodies and CD: past and future of celiac antibody testing.
Korponay-Szabó IR
J Pediatr Gastroenterol Nutr; 2014 Jul; 59 Suppl 1():S11-3. PubMed ID: 24979192
[TBL] [Abstract][Full Text] [Related]
36. Two novel HLA-DQ2.5-restricted gluten T cell epitopes in the DQ2.5-glia-γ4 epitope family.
Qiao SW; Sollid LM
Immunogenetics; 2019 Nov; 71(10):665-667. PubMed ID: 31673720
[TBL] [Abstract][Full Text] [Related]
37. Gluten-specific antibodies of celiac disease gut plasma cells recognize long proteolytic fragments that typically harbor T-cell epitopes.
Dørum S; Steinsbø Ø; Bergseng E; Arntzen MØ; de Souza GA; Sollid LM
Sci Rep; 2016 May; 6():25565. PubMed ID: 27146306
[TBL] [Abstract][Full Text] [Related]
38. Celiac disease: Autoimmunity in response to food antigen.
Stamnaes J; Sollid LM
Semin Immunol; 2015 Sep; 27(5):343-52. PubMed ID: 26603490
[TBL] [Abstract][Full Text] [Related]
39. Epitope mapping of the N-terminal portion of tissue transglutaminase protein antigen to identify linear epitopes in celiac disease.
Di Pisa M; Buccato P; Sabatino G; Real Fernández F; Berti B; Cocola F; Papini AM; Rovero P
J Pept Sci; 2014 Sep; 20(9):689-95. PubMed ID: 24831711
[TBL] [Abstract][Full Text] [Related]
40. T-cell response to gluten in patients with HLA-DQ2.2 reveals requirement of peptide-MHC stability in celiac disease.
Bodd M; Kim CY; Lundin KE; Sollid LM
Gastroenterology; 2012 Mar; 142(3):552-61. PubMed ID: 22108197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
